SEC Filings
| Filing date | Form | Description | View |
|---|---|---|---|
| 10-Q | Quarterly report which provides a continuing view of a company's financial position |
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3/A | An amendment to a 3 filing. Non-EDGAR filing |
View HTML | |
| 3 | Initial filing by director officer or owner of more than ten percent |
View HTML | |
| 3 | Initial filing by director officer or owner of more than ten percent |
View HTML | |
| 3 | Initial filing by director officer or owner of more than ten percent |
View HTML |
Displaying 951 - 960 of 1006 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.
